Circulation, Vol 54, 849-861, Copyright © 1976 by American Heart Association
E Haber
Recently, the availability of a number of specific inhibitors of the
renin-angiotensin system has made it possible to address certain critical
questions concerning the role of angiotensin II in physiologic homeostasis
and in a number of pathologic states. These studies indicate that
angiotensin II does not have an obligatory role in blood pressure
maintenance in the normal, sodium replete individual, but it is essential
following sodium depletion. The role of angiotensin II in feedback control
of renin secretion is confirmed as is its importance in aldosterone
stimulation both in relation to posture and sodium depletion. Angiotensin
II is responsible for the initial pressor response of experimental
renovascular hypertension and appears to be important in the initiation of
chronic renovascular hypertension. Converting enzyme blockers and
competitive inhibitors of angiotensin II are helpful in the diagnosis of
clinical renovascular hypertension and in the identification of renin
dependent hypertensives. Homeostatic mechanisms leading to maintenance of
blood pressure and accumulation of edema in experimental congestive heart
failure appear to be dependent on angiotensin II.
ARTICLES
George C. Griffith lecture. The role of renin in normal and pathological cardiovascular homeostasis
This article has been cited by other articles:
![]() |
S. D. Solomon and M. A. Pfeffer Aldosterone antagonism and myocardial infarction: From animals to man and back J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1674 - 1676. [Full Text] [PDF] |
||||
![]() |
F. Ryckwaert, P. Colson, E. Andre, P.-F. Perrigault, G. Guillon, and C. Barberis Haemodynamic effects of an angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist during hypovolaemia in the anaesthetized pig Br. J. Anaesth., October 1, 2002; 89(4): 599 - 604. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. E. S. Sibinga and J. A. Ware A Pair of ACEs, for Openers? Circ. Res., September 29, 2000; 87(7): 523 - 525. [Full Text] [PDF] |
||||
![]() |
E. Napoleone, A. Di Santo, M. Camera, E. Tremoli, and R. Lorenzet Angiotensin-Converting Enzyme Inhibitors Downregulate Tissue Factor Synthesis in Monocytes Circ. Res., February 4, 2000; 86(2): 139 - 143. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Colson, F. Ryckwaert, and P. Coriat Renin Angiotensin System Antagonists and Anesthesia Anesth. Analg., November 1, 1999; 89(5): 1143 - 1143. [Full Text] [PDF] |
||||
![]() |
N. K. Hollenberg, N. D. L. Fisher, and D. A. Price Pathways for Angiotensin II Generation in Intact Human Tissue : Evidence From Comparative Pharmacological Interruption of the Renin System Hypertension, September 1, 1998; 32(3): 387 - 392. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Allan, K. Y. Hui, C. Coletti, and N. K. Hollenberg Renin vs. Angiotensin-Converting Enzyme Inhibition in the Rat: Consequences for Plasma and Renal Tissue Angiotensin J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 661 - 665. [Abstract] [Full Text] |
||||
![]() |
G. G. N. Serneri, M. Boddi, M. Coppo, T. Chechi, N. Zarone, M. Moira, L. Poggesi, M. Margheri, and I. Simonetti Evidence for the Existence of a Functional Cardiac Renin-Angiotensin System in Humans Circulation, October 15, 1996; 94(8): 1886 - 1893. [Abstract] [Full Text] |
||||
![]() |
N. K. Hollenberg and N. D. L. Fisher Renal Circulation and Blockade of the Renin-Angiotensin System : Is Angiotensin-Converting Enzyme Inhibition the Last Word? Hypertension, October 1, 1995; 26(4): 602 - 609. [Abstract] [Full Text] |
||||
![]() |
R. N. Re Cellular Biology of the Renin-Angiotensin Systems Arch Intern Med, October 1, 1984; 144(10): 2037 - 2041. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1976 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |